Accessibility Menu
 
Novozymes A/s logo

Novozymes A/s

(OTC) NVZMY

Current Price$62.43
Market Cap$25.73B
Since IPO (2003)+1,722%
5 Year-5%
1 Year-4%
1 Month+4%

Novozymes A/s Financials at a Glance

Market Cap

$25.73B

Revenue (TTM)

$11.01B

Net Income (TTM)

$583.60M

EPS (TTM)

$1.40

P/E Ratio

44.40

Dividend

$1.00

Beta (Volatility)

0.49 (Low)

Price

$62.43

Volume

64,544

Open

$61.84

Previous Close

$62.43

Daily Range

$61.13 - $63.10

52-Week Range

$49.90 - $75.99

NVZMY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novozymes A/s

Industry

Chemicals

Sector

Materials

Employees

11,641

CEO

Ester Baiget, MBA

Headquarters

Bagsvaerd, 2880, DK

NVZMY Financials

Key Financial Metrics (TTM)

Gross Margin

54%

Operating Margin

21%

Net Income Margin

14%

Return on Equity

5%

Return on Capital

6%

Return on Assets

4%

Earnings Yield

2.25%

Dividend Yield

1.61%

Payout Ratio

68.92%

Stock Overview

Market Cap

$25.73B

Shares Outstanding

412.17M

Volume

64.54K

Avg. Volume

117.78K

Financials (TTM)

Gross Profit

$2.24B

Operating Income

$882.60M

EBITDA

$1.39B

Operating Cash Flow

$1.22B

Capital Expenditure

$470.80M

Free Cash Flow

$750.70M

Cash & ST Invst.

$295.60M

Total Debt

$22.45B

Novozymes A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$996.60M

-86.6%

Gross Profit

$558.80M

-46.4%

Gross Margin

56.07%

N/A

Market Cap

$25.73B

N/A

Market Cap/Employee

$2.43M

N/A

Employees

10,582

N/A

Net Income

$765.20M

-416.3%

EBITDA

$270.81M

-37.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$22.15B

-1364.2%

Accounts Receivable

$869.40M

+8.1%

Inventory

$772.20M

+7.2%

Long Term Debt

$9.74B

+536.3%

Short Term Debt

$12.71B

+4670.1%

Return on Assets

3.57%

N/A

Return on Invested Capital

6.49%

N/A

Free Cash Flow

$101.50M

-63.7%

Operating Cash Flow

$328.20M

-33.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SKFOFSika AG
$179.05-2.71%
SXYAYSika AG
$18.34-0.60%
AKZOYAkzo Nobel N.V.
$19.47-0.41%
GVDBFGivaudan S.A.
$3383.37+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$50.22-0.03%

Questions About NVZMY

What is the current price of Novozymes A/s?

Novozymes A/s is trading at $62.43 per share.

What is the 52-week range for Novozymes A/s?

Over the past 52 weeks, Novozymes A/s has traded between $49.90 and $75.99.

How much debt does Novozymes A/s have?

As of the most recent reporting period, Novozymes A/s reported total debt of $3.53B.

How much cash does Novozymes A/s have on hand?

Novozymes A/s reported $323.33M in cash and cash equivalents in its most recent financial results.

What is Novozymes A/s’s dividend yield?

Novozymes A/s currently has a dividend yield of 1.61%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.